Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies (Q38183131)

30 August 2017

0 references

Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies (English)

1 reference

30 August 2017

0 references

1 reference

1 reference

C Merlotti

1

1 reference

PubMed ID

24476122

30 August 2017

A Morabito

series ordinal

2

1 reference

PubMed ID

24476122

30 August 2017

A E Pontiroli

series ordinal

3

1 reference

30 August 2017

27 February 2014

1 reference

Diabetes, Obesity and Metabolism

30 August 2017

1 reference

30 August 2017

16

1 reference

30 August 2017

8

1 reference

30 August 2017

719-727

1 reference

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

30 August 2017

1 reference

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

21 January 2018

1 reference

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

21 January 2018

1 reference

Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR).

21 January 2018

1 reference

Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists

21 January 2018

1 reference

Have clinical studies demonstrated diabetes prevention or delay of diabetes through early treatment?

21 January 2018

1 reference

Reducing diabetes incidence through the inhibition of the renin-angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?

21 January 2018

1 reference

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

21 January 2018

1 reference

Oral anti-diabetic drugs for the prevention of Type 2 diabetes

21 January 2018

1 reference

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

21 January 2018

1 reference

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance

21 January 2018

1 reference

Tale of two churches: differential impact of a church-based diabetes control programme among Pacific Islands people in New Zealand.

21 January 2018

1 reference

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

21 January 2018

1 reference

Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance

21 January 2018

1 reference

Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial

21 January 2018

1 reference

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

21 January 2018

1 reference

Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study

21 January 2018

1 reference

Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK.

21 January 2018

1 reference

Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial

21 January 2018

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

21 January 2018

1 reference

Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial

21 January 2018

1 reference

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

21 January 2018

1 reference

Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland

21 January 2018

1 reference

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions

21 January 2018

1 reference

Reduced progression to type 2 diabetes from impaired glucose tolerance after a 2-day in-hospital diabetes educational program: the Joetsu Diabetes Prevention Trial

21 January 2018

1 reference

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.

21 January 2018

1 reference

A trial of simple versus intensified dietary modification for prevention of progression to diabetes mellitus in women with impaired glucose tolerance

21 January 2018

1 reference

Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial.

21 January 2018

1 reference

Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS).

21 January 2018

1 reference

Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial

21 January 2018

1 reference

Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative

21 January 2018

1 reference

Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes

21 January 2018

1 reference

Moderate alcohol consumption is associated with lower risk for incident diabetes and mortality: the Hoorn Study

21 January 2018

1 reference

Alcohol consumption and type 2 diabetes among older adults: the Cardiovascular Health Study.

21 January 2018

1 reference

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance

21 January 2018

1 reference

Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance

21 January 2018

1 reference

Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes

21 January 2018

1 reference

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).

21 January 2018

1 reference

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

21 January 2018

1 reference

Pioglitazone for diabetes prevention in impaired glucose tolerance.

21 January 2018

1 reference

Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes.

21 January 2018

1 reference

Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes")

21 January 2018

1 reference

Effect of metformin on patients with impaired glucose tolerance.

21 January 2018

1 reference

Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.

21 January 2018

1 reference

Effect of nateglinide on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

Efficacy of acarbose in Chinese subjects with impaired glucose tolerance

21 January 2018

1 reference

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

21 January 2018

1 reference

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease

21 January 2018

1 reference

Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients

21 January 2018

1 reference

Antidiabetic action of bezafibrate in a large observational database

21 January 2018

1 reference

Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study

21 January 2018

1 reference

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study.

21 January 2018

1 reference

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

21 January 2018

1 reference

Ramipril and the development of diabetes.

21 January 2018

1 reference

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

21 January 2018

1 reference

Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension

21 January 2018

1 reference

Effect of ramipril on the incidence of diabetes

21 January 2018

1 reference

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

21 January 2018

1 reference

Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Pr

21 January 2018

1 reference

Effect of valsartan on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).

21 January 2018

1 reference

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Transdermal 17-beta-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women

21 January 2018

1 reference

The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial

21 January 2018

1 reference

Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review

21 January 2018

1 reference

Effect of weight-reducing agents on glycaemic parameters and progression to Type 2 diabetes: a review

21 January 2018

1 reference

The role of physical activity in the management of impaired glucose tolerance: a systematic review

21 January 2018

1 reference

Pharmacologic prevention or delay of type 2 diabetes mellitus

21 January 2018

1 reference

A systematic review of drug therapy to delay or prevent type 2 diabetes.

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

Publication bias in clinical research

21 January 2018

1 reference

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?

21 January 2018

1 reference

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

21 January 2018

1 reference

Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program

21 January 2018

1 reference

Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data

21 January 2018

1 reference

Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12270

1 reference

30 August 2017

1 reference

PubMed ID

24476122